Variable adoption of intrapleural fibrinolytic therapy for pleural space infections
A. Jackson (Seattle, United States of America), J. Rayburn (Seattle, United States of America), C. Fuller (Seattle, United States of America), C. Wilshire (Seattle, United States of America), C. Gilbert (Seattle, United States of America), B. Louie (Seattle, United States of America), R. Aye (Seattle, United States of America), E. Vallières (Seattle, United States of America), A. Farivar (Seattle, United States of America), A. Bograd (Seattle, United States of America), K. Costas (Everett, United States of America), J. Handy (Portland, United States of America), S. Kotova (Portland , United States of America), J. Gorden (Seattle, United States of America)
Source: International Congress 2018 – Pleural interventions
Session: Pleural interventions
Session type: Thematic Poster
Number: 891
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Jackson (Seattle, United States of America), J. Rayburn (Seattle, United States of America), C. Fuller (Seattle, United States of America), C. Wilshire (Seattle, United States of America), C. Gilbert (Seattle, United States of America), B. Louie (Seattle, United States of America), R. Aye (Seattle, United States of America), E. Vallières (Seattle, United States of America), A. Farivar (Seattle, United States of America), A. Bograd (Seattle, United States of America), K. Costas (Everett, United States of America), J. Handy (Portland, United States of America), S. Kotova (Portland , United States of America), J. Gorden (Seattle, United States of America). Variable adoption of intrapleural fibrinolytic therapy for pleural space infections. 891
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The effect of intrapleural fibrinolytic therapy in the drainage of loculated haemorrhagic effusions Source: Eur Respir J 2001; 18: Suppl. 33, 387s Year: 2001
An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection Source: ERJ Open Res, 8 (1) 00590-2021; 10.1183/23120541.00590-2021 Year: 2022
Intrapleural streptokinase in the management of loculated pleural fluids of various aetiologies Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010
Intrapleural fibrinolytic treatment of empyemas Source: Eur Respir J 2005; 26: Suppl. 49, 491s Year: 2005
Efficacy of intrapleural streptokinase use in complicated parapneumonic pleural effusions and empyema Source: Annual Congress 2008 - Pleural effusion Year: 2008
Respiratory functional status after intrapleural t-PA administration for complicated parapneumonic effusions Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012
Malignant pleural effusion: treatment of the fluid and intrapleural therapy Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural effusion Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases Year: 2009
Intrapleural fibrinolysis modulation in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 517s Year: 2001
Primary thoracoscopy versus fibrinolysis in the management of pleural sepsis Source: Eur Respir J 2004; 24: Suppl. 48, 51s Year: 2004
A clinical comparison of intrapleural heparin versus urokinase in the management of tuberculous pleurisy Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005
Intrapleural tPA increases pleural fluid output in pleural infection, independent of chest X-ray opacification Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Safety and efficacy of reduced dose intrapleural alteplase and DNAase for pleural infection Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018
Effectiveness and safety of tunneled pleural catheter placement in patients with malignant pleural effusions Source: International Congress 2019 – Interventional pulmonology: current pleural practice Year: 2019
Intrapleural urokinase in the management of empyema in children Source: Eur Respir J 2004; 24: Suppl. 48, 620s Year: 2004
Efficacy and complications of small-bore catheters in the management of malignant pleural effusions Source: Eur Respir J 2007; 30: Suppl. 51, 103s Year: 2007
Intrapleural tenectaplase therapy in treatment of loculated parapneumonic pleural effusions and empyema Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015
Intrapleural fibrinolytic treatment with streptokinase for empyema during pregnancy: 2 cases Source: Annual Congress 2010 - Infections and pleural problems Year: 2010
Role of pleural irrigation with normal saline versus streptokinase in complicated pleural effusions. Source: International Congress 2019 – Interventional pulmonology: current pleural practice Year: 2019
Management of malignant pleural effusion in recurrent SCLC by intrapleural gene therapy Source: Eur Respir J 2003; 22: Suppl. 45, 61s Year: 2003